SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Free Report) - Research analysts at Sidoti Csr cut their FY2024 earnings estimates for SBC Medical Group in a note issued to investors on Wednesday, March 26th. Sidoti Csr analyst A. Shah now expects that the company will post earnings per share of $0.57 for the year, down from their previous estimate of $0.58. The consensus estimate for SBC Medical Group's current full-year earnings is $5.02 per share. Sidoti Csr also issued estimates for SBC Medical Group's Q1 2025 earnings at $0.16 EPS, Q2 2025 earnings at $0.16 EPS, Q3 2025 earnings at $0.16 EPS, Q4 2025 earnings at $0.15 EPS, FY2025 earnings at $0.64 EPS, Q1 2026 earnings at $0.17 EPS, Q2 2026 earnings at $0.18 EPS, Q3 2026 earnings at $0.18 EPS, Q4 2026 earnings at $0.19 EPS and FY2026 earnings at $0.71 EPS.
SBC Medical Group (NASDAQ:SBC - Get Free Report) last announced its earnings results on Friday, March 28th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.01. The business had revenue of $57.90 million for the quarter, compared to analysts' expectations of $56.34 million.
SBC Medical Group Trading Down 0.9 %
SBC stock traded down $0.03 during midday trading on Thursday, reaching $3.25. 7,961 shares of the company traded hands, compared to its average volume of 59,357. The company has a debt-to-equity ratio of 0.06, a current ratio of 2.79 and a quick ratio of 2.76. The stock's 50 day simple moving average is $4.41. SBC Medical Group has a 52-week low of $2.62 and a 52-week high of $12.50.
About SBC Medical Group
(
Get Free Report)
SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.
Featured Articles
Before you consider SBC Medical Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SBC Medical Group wasn't on the list.
While SBC Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
